Mangoceuticals (MGRX) Stock Price

Mangoceuticals Price

NASDAQ·CLOSED
0.45
​
Market closed

Revenue has compounded at 270.9% per year over the past 3 years to 456,021.00 USD. Mangoceuticals's net margin stands at -4,526.9%, up from -22,352.1% several years earlier.

Mangoceuticals stock price

Access this data via the Eulerpool API

Mangoceuticals business model & stock analysis

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

Frequently asked questions about Mangoceuticals

Converted at the current exchange rate, the Mangoceuticals share trades at 0.40 EUR (0.45 USD).

The Mangoceuticals share (MGRX) is listed on 1 stock exchanges, including: NASDAQ (MGRX).

The revenue cannot currently be calculated for Mangoceuticals.

The profit cannot currently be calculated for Mangoceuticals.

The P/E ratio cannot be calculated for Mangoceuticals at the moment.

The P/S cannot be calculated for Mangoceuticals currently.

The Eulerpool Quality Score for Mangoceuticals is 3/10.

The ISIN of Mangoceuticals is US56270V2051. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Mangoceuticals is MGRX. The ticker symbol is used to trade Mangoceuticals shares on the stock exchange.

Fair ValueTerminal
0.37 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Consumer Staples Distribution & Retail
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website mangorx.com
Currency
USD
Initial public offering
Mar 21, 2023
ISIN
US56270V2051
Cusip
56270V106
Market capitalization
6.87 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.45
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-133.11 %
Last updated Oct 10, 2026, 1:07 AM

Mangoceuticals Peer Group

Mangoceuticals Ticker

NASDAQ · MGRX